Article

For dry eye patients punctal plugs offer flow control

Soft Plug Flow Control Silicone Plugs (Oasis Medical) provide partial occlusion of the puncta with limited tear drainage for patients with moderate and severe dry eye. These plugs eliminate epiphora in patients for whom total occlusion is excessive.

Key Points

"Punctal plugs are beneficial for a large number of patients with dry eye. However, there are circumstances in which the total occlusion of the puncta in the upper and lower lids provided by standard punctal plugs is excessive, and when patients have reflex tearing they have tears running down their faces, as might happen on a windy day," he said. "The flow control design allows some of the extra tears to move through the opening in the plug, which is a smaller orifice than the puncta of most patients. So less tears are flowing out, but there is some outflow, which is basic fluid mechanics." Dr. Kirby is in private practice in Chattanooga, TN.

In his practice, he does not use the flow control plugs as the first treatment in patients who receive punctal plugs but uses them to fine-tune the results. The standard nonperforated plugs may be adequate in some patients but too much occlusion in others. In the latter group, some patients may have intermittent epiphora, and the standard plug can be removed and replaced with a perforated plug.

He also said that he uses the perforated plug for patients being treated with cyclosporine (Restasis, Allergan) whose clinical situation has been improving as a result of treatment with the drug, but is not yet perfect.

"These perforated plugs represent an interim step in the treatment of these patients who don't need full occlusion," Dr. Kirby said.

"Some of the happiest patients in my practice are those who had a nonperforated plug in the upper lid that was replaced with a perforated flow control plug. This change gives them the slight adjustment that they needed," he added.

The plugs, introduced December 2008, come preloaded on a disposable inserter and are available in two sizes, 0.6 and 0.7 mm. The insertion technique is the same as that used with a standard punctal plug, Dr. Kirby said.

"The usefulness of this product lies in its ability to fine-tune the treatment of moderate and severe dry eye. These patients need some outflow of tears when the total occlusion provided by the standard punctal plugs is too much," he concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.